What's New
Health Professional Communication
Droperidol Injection USP - Association with Severe Arrhythmia - Sandoz Canada Inc.
Droperidol Injection USP is associated with severe arrhythmia and the Canadian Monograph of this product has been updated to reflect this risk.
Health Professional Communication
Notice to Hospitals
Delivery of Topical Hemostatic Agents Using Spray Devices - Association with Air/Gas Embolism
Cases of air embolism have been reported with inappropriate use of spray devices and pressurized gas to apply topical hemostatic agents.
Notice to Hospitals
Information Update
Important Diabetes Information: GlucaGen Hypokit being Recalled in Canada
Health Canada is informing Canadians that Novo Nordisk Canada Inc. has agreed to voluntarily recall two lots (YW60335 and YW60351) of their product, GlucaGen Hypokit (DIN 02333627) currently available on the Canadian market.
Information Update
National Drug Scheduling Advisory Committee Meeting – September 12, 2010
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for September 12, 2010. The primary purpose of the meeting is to consider the following matter:
- Request for a change in scheduling of naproxen sodium 220 mg per tablet to Unscheduled.
[> More]